Drug Shortage Report for BREO ELLIPTA
Report ID | 174375 |
Drug Identification Number | 02408872 |
Brand name | BREO ELLIPTA |
Common or Proper name | fluticasone furoate/vilanterol (as trifenatate) dry powder for oral inhalation |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE FUROATE VILANTEROL |
Strength(s) | 100MCG 25MCG |
Dosage form(s) | POWDER |
Route of administration | INHALATION INHALATION |
Packaging size | 1x30 |
ATC code | R03AK |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-10 |
Estimated end date | 2022-12-02 |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2022-12-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-01 | English | Compare |
v4 | 2022-11-30 | French | Compare |
v3 | 2022-11-30 | English | Compare |
v2 | 2022-11-11 | French | Compare |
v1 | 2022-11-11 | English | Compare |
Showing 1 to 5 of 5